DANAHER CORPORATION Inactive Instrument
Danaher Corporation Share Price Swiss Exchange
Equities
DHR
US2358511028
Advanced Medical Equipment & Technology
| Sales 2024 * | 23.88B 21.51B 1,993B | Sales 2025 * | 25.97B 23.39B 2,167B | Capitalization | 178B 160B 14,835B |
|---|---|---|---|---|---|
| Net income 2024 * | 4.42B 3.98B 368B | Net income 2025 * | 5.36B 4.83B 448B | EV / Sales 2024 * | 7.8 x |
| Net Debt 2024 * | 8.54B 7.69B 712B | Net Debt 2025 * | 2.7B 2.43B 225B | EV / Sales 2025 * | 6.95 x |
| P/E ratio 2024 * |
40.5
x | P/E ratio 2025 * |
33.3
x | Employees | 62,000 |
| Yield 2024 * |
0.45% | Yield 2025 * |
0.48% | Free-Float | 74.91% |
More Fundamentals
* Assessed data
More news
Latest transcript on Danaher Corporation
More recommendations
More press releases
More news
| Managers | Title | Age | Since |
|---|---|---|---|
Steven Rales
FOU | Founder | 72 | 01/83/01 |
Rainer Blair
CEO | Chief Executive Officer | 60 | 01/10/01 |
Mitchell Rales
FOU | Founder | 67 | 01/83/01 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Mitchell Rales
FOU | Founder | 67 | 01/83/01 |
Alan Spoon
BRD | Director/Board Member | 72 | 01/99/01 |
Steven Rales
FOU | Founder | 72 | 01/83/01 |
Danaher Corporation is an industrial and technologic group organized around two families of products:
- medical equipment (70.1% of net sales): diagnostic equipment, digital imaging systems, optical instruments, microscopes, consumables, etc.;
- professional instruments of analysis (29.9%): systems of quality control of waters, disinfection, etc.
Net sales are distributed geographically as follows: the United States (40.1%), China (13.2%) and other (46.7%).
Calendar
23/07/2024
- Q2 2024 Earnings Release
Related indices
| 1st Jan change | Capi. | |
|---|---|---|
| +0.91% | 204B | |
| +28.89% | 154B | |
| +31.66% | 112B | |
| +1.37% | 64.16B | |
| +19.45% | 54.88B | |
| -3.44% | 46.69B | |
| -9.28% | 36.8B | |
| -0.10% | 35.26B | |
| +10.10% | 27.82B |
